STOCK TITAN

NYSE flags SOLAI (NYSE: SLAI) price compliance as board gains new director

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

SOLAI Limited reported that the New York Stock Exchange notified the company on January 29, 2026 that its ADSs no longer meet the NYSE’s minimum US$1.00 average closing price requirement over a 30‑day period. SOLAI has a six‑month cure period to restore compliance or face potential suspension and delisting procedures, though trading continues and the company remains compliant with all other NYSE standards. The notice does not affect day‑to‑day operations or SEC reporting. SOLAI also announced that independent director Qian Sun resigned for personal reasons and was immediately replaced by new independent director Zhan Chen, who will join key board committees and brings prior entrepreneurial and executive experience in consumer, technology, and fintech businesses.

Positive

  • None.

Negative

  • NYSE minimum price deficiency and delisting risk: SOLAI’s ADSs failed to meet the NYSE’s US$1.00 minimum average closing price requirement over 30 consecutive trading days, starting a six‑month cure period after which the NYSE may commence suspension and delisting procedures if compliance is not restored.

Insights

NYSE price deficiency raises listing risk as SOLAI refreshes its board.

SOLAI Limited has fallen out of compliance with the NYSE’s US$1.00 minimum average closing price requirement for its ADSs, triggering a formal six‑month cure period. If the company cannot restore price compliance by the end of this window, the NYSE may begin suspension and delisting procedures.

The company states that trading continues and that it remains in compliance with all other NYSE listing standards, so immediate operational impact is limited. However, the potential loss of a major U.S. listing venue is typically seen as a material governance and capital‑markets risk for shareholders.

On governance, SOLAI is managing board turnover by replacing long‑serving independent director Qian Sun with new independent director Zhan Chen, who also joins the audit, nominating and corporate governance, and strategy committees. Future disclosures in company filings may provide more detail on how SOLAI plans to regain compliance with the NYSE’s price standard.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2026

 

Commission File Number: 001-36206

 

SOLAI Limited

 

428 South Seiberling Street

Akron, Ohio 44306

United States of America

+1 (346) 204-8537

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x         Form 40-F ¨

 

 

 

 

 

 

TABLE OF CONTENTS

 

Exhibit 99.1     Press Release - SOLAI Limited Receives Continued Listing Notice from NYSE; Announces Changes to its Board of Directors

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

      SOLAI LIMITED
         
      By: /s/ Xianfeng Yang
      Name: Xianfeng Yang
      Title: Chief Executive Officer
         
Date: February 27, 2026      

 

 

 

 

Exhibit 99.1

 

SOLAI Limited Receives Continued Listing Notice from NYSE;
Announces Changes to its Board of Directors

 

AKRON, Ohio, February 27, 2026 – SOLAI Limited (NYSE: SLAI) (previously traded under “BTCM”) (“SOLAI” or the “Company”), a leading technology-driven cryptocurrency infrastructure company, today announced that on January 29, 2026, the Company was notified by the New York Stock Exchange (“NYSE”) that it is not in compliance with continued listing standards set forth in Section 802.01C of the NYSE Listed Company Manual because as of January 28, 2026, the average closing price of the Company’s American Depositary Shares (“ADSs”) was less than US$1.00 per ADS over a consecutive 30 trading-day period.

 

The Company notified the NYSE on February 10, 2026, of its intent to regain compliance with the minimum price requirement.

 

The Company has six months (“the Cure Period”) following receipt of the notice to regain compliance with the minimum share price requirement. The Company can regain compliance at any time during the six-month Cure Period if, on the last trading day of any calendar month during the Cure Period, its ADSs have a closing price of at least US$1.00 and an average closing price of at least US$1.00 over the 30 consecutive trading-day period ending on the last trading day of that month. If such compliance with the minimum share price requirement has not been regained by the end of the Cure Period, the NYSE will commence suspension and delisting procedures.

 

The notice has no immediate impact on the listing of the Company’s ADSs, which will continue to be listed and traded on the NYSE, subject to compliance with other NYSE continued listing standards and other rights of the NYSE to delist the ADSs. The Company is currently in compliance with all other NYSE continued listing standards. The notice does not affect the Company’s business operations, its U.S. Securities and Exchange Commission reporting requirements or contractual obligations. The Company is closely monitoring the closing price of its ADSs and intends to regain compliance.

 

Changes to Board of Directors

 

The Company also announced that Mr. Qian Sun has resigned as an independent director, effective immediately. Mr. Sun’s resignation is for personal reasons and does not involve any disagreement with the Company’s Board of Directors (the “Board”). Mr. Sun expressed his gratitude for the opportunity to serve the Company and wished it continued success.

 

Concurrently, SOLAI appointed Mr. Zhan Chen as an independent director of the Company, effective immediately. Mr. Chen satisfies the requirements for an “independent director” within the meaning of Section 303A of the Corporate Governance Rules of the NYSE, and meets the criteria for independence set forth in Rule 10A-3 of the Securities Exchange Act of 1934, as amended. Mr. Chen will succeed Mr. Sun as a member of the audit committee, the nominating and corporate governance committee, and the strategy committee of the Board.

 

Mr. Chen brings extensive entrepreneurial and executive leadership experience across the consumer, technology, and fintech sectors in both the U.S. and Asia. He is the founder and, since 2025, the CEO of Open Mouth Food Inc., a U.S.-based premium food company specializing in clean-label, shelf-stable Asian noodle soups and broths. Previously, Mr. Chen successfully founded and scaled multiple ventures, serving as CEO of Boba Labs Inc. from 2022 to 2024 and Qin Yan Tech from 2017 to 2019. Earlier in his career, he served as CEO of the consumer lending division at Wheat Financial Technology. Mr. Chen received a bachelor’s degree from the East China University of Political Science and Law. He is an alumnus of Tsinghua University’s Global Entrepreneur Leadership Program at the PBC School of Finance, a curriculum tailored for founders, entrepreneurs, and senior investment professionals driving innovative, high-growth ventures. He also completed an executive education program at China Europe International Business School (“CEIBS”).

 

 

 

 

Mr. Bo Yu, the Chairman of the Board and Chief Operating Officer of SOLAI, commented, “On behalf of the Board and the entire management team, I would like to extend our deepest gratitude to Mr. Sun for his invaluable guidance and dedicated service since 2013. We wish him the absolute best in his future endeavors as he returns to his commitments at HSG. As we develop our strategy, infrastructure, and products to drive the next phase of growth, we are very excited to welcome Mr. Chen to the Board. His proven leadership and dynamic entrepreneurial track record having founded and scaled ventures across the consumer, fintech, and broader technology sectors will bring fresh, highly relevant perspectives to the Board.”

 

About SOLAI Limited

 

SOLAI Limited (previously known as “BIT Mining Limited”) (NYSE: SLAI) (previously traded under “BTCM”), is a technology-driven cryptocurrency infrastructure company expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins and payment infrastructure, and Solana treasury and staking operations — supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. By leveraging its blockchain and data infrastructure expertise, SOLAI aims to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.

 

Forward-Looking Statements

 

This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “going forward,” “outlook” and similar statements. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Important factors that could cause SOLAI’s actual results to differ materially from those indicated in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

 

 

 

 

For further information:

 

SOLAI Limited

ir@solai.com

ir.solai.com

www.solai.com

 

Christensen Advisory

Jason Ng

Tel: +852-2117-0861

Email: solai@christensencomms.com

 

 

 

FAQ

What NYSE listing issue did SOLAI Limited (SLAI) disclose?

SOLAI disclosed that the NYSE notified it on January 29, 2026 that its ADSs no longer meet Section 802.01C’s US$1.00 minimum average closing price standard, based on the 30 trading days ended January 28, 2026. This triggers a formal price‑compliance cure period.

How long does SOLAI (SLAI) have to regain NYSE price compliance?

SOLAI has six months from receiving the NYSE notice to regain compliance. The company must achieve at least US$1.00 closing price on the last trading day of a month and a US$1.00 30‑day average ending that day to cure the deficiency.

Will SOLAI’s ADSs be immediately suspended or delisted from the NYSE?

No, the notice has no immediate impact on listing. SOLAI’s ADSs continue trading on the NYSE while it works to regain compliance and remains subject to all other continued listing standards and the NYSE’s general delisting rights.

Does the NYSE price notice affect SOLAI’s operations or SEC reporting?

The company states the notice does not affect business operations, SEC reporting obligations, or contractual commitments. The issue concerns only compliance with the NYSE’s minimum price standard for ADSs, not operational performance or regulatory filing requirements.

What board changes did SOLAI Limited (SLAI) announce?

SOLAI announced that independent director Qian Sun resigned for personal reasons and without disagreement with the board. The company simultaneously appointed Zhan Chen as a new independent director, assigning him to the audit, nominating and corporate governance, and strategy committees.

Who is SOLAI’s new independent director, Zhan Chen?

Zhan Chen is an entrepreneur and executive with experience in consumer, technology, and fintech sectors in the U.S. and Asia. He founded Open Mouth Food Inc. and previously led ventures including Boba Labs Inc. and Qin Yan Tech, and has additional executive education in finance and business.

Filing Exhibits & Attachments

1 document